4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Delcath Systems, Inc. (DCTH) operates in the Medical Devices industry and is headquartered in Queensbury, United States with about 156 employees. Its market capitalization is roughly $467 million. In the fiscal year ended 2025-12-31, DCTH reported $85M in revenue and $3M in net income.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.
Interactive charts & full statements → Open the DCTH valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $85M | $37M | $2M | $3M | — |
| Gross Profit | $73M | $31M | $1M | $2M | — |
| Operating Income (EBIT) | $1M | ($12M) | ($38M) | ($34M) | — |
| Net Income | $3M | ($26M) | ($48M) | ($36M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $25M | $21M | $21M | $24M | $20M | — |
| Gross Profit | $21M | $18M | $18M | $21M | $17M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($0M) | $3M | $1M | — |
| Net Income | ($1M) | ($2M) | $1M | $3M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $124M | $77M | $39M | $18M | — |
| Total Liabilities | $12M | $8M | $23M | $24M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DCTH viewer.
About TickerBase · Data methodology & sources